Trademark: 90800831
Word
AUCTA PHARMACEUTICALS
Status Date
Tuesday, December 19, 2023
Filing Date
Tuesday, June 29, 2021
Published for Opposition
Tuesday, November 1, 2022
5 Pharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; Pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression
The mark consists of an image of a triangle inside a square located to the left of the wording "AUCTA" stacked above the term "PHARMACEUTICALS".
Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"
Dec 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 19, 2023
Sou Extension 2 Granted
Dec 19, 2023
Sou Extension 2 Filed
Dec 19, 2023
Sou Teas Extension Received
Jun 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2023
Sou Extension 1 Granted
Jun 27, 2023
Sou Extension 1 Filed
Jun 27, 2023
Sou Teas Extension Received
Dec 27, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2022
Published For Opposition
Oct 12, 2022
Notification Of Notice Of Publication E-Mailed
Sep 26, 2022
Approved For Pub - Principal Register
Sep 21, 2022
Teas/Email Correspondence Entered
Sep 21, 2022
Correspondence Received In Law Office
Sep 21, 2022
Teas Response To Office Action Received
Mar 22, 2022
Notification Of Non-Final Action E-Mailed
Mar 22, 2022
Non-Final Action E-Mailed
Mar 22, 2022
Non-Final Action Written
Mar 21, 2022
Assigned To Examiner
Sep 11, 2021
Notice Of Design Search Code E-Mailed
Sep 10, 2021
New Application Office Supplied Data Entered
Jul 2, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
